Patent · US Active

Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth

US7605240B2 · kind B2 · utility

36Cited by
91References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2007
Grant dateOct 20, 2009
Priority date
Expiry dateAug 14, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/065
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a method of diagnosing irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, or Crohn's disease, which involves detecting the presence of small intestinal bacterial overgrowth (SIBO) in a human subject having at least one symptom associated with a suspected diagnosis of any of those diagnostic categories. Also disclosed is a method of treating these disorders, and other disorders caused by SIBO, that involves at least partially eradicating a SIBO condition in the human subject. The method includes administration of anti-microbial or probiotic agents, or normalizing intestinal motility by employing a prokinetic agent. The method improves symptoms, including hyperalgesia related to SIBO and disorders caused by SIBO. Also disclosed is a kit for the diagnosis or treatment of irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, or Crohn's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.